Schedule 13G ownership disclosure

Alto Neuroscience Inc

Common Stock, $0.0001 par value per share · CUSIP: 02157Q109

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Commodore Capital LP

    Shares: 3,245,628.00 · Class: 9.9%

  • Commodore Capital Master LP

    Shares: 3,245,628.00 · Class: 9.9%

  • Robert Egen Atkinson

    Shares: 3,245,628.00 · Class: 9.9%

  • Michael Kramarz

    Shares: 3,245,628.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001831942-26-000005
Form type
SCHEDULE 13G/A
Filer
Alto Neuroscience, Inc.
CIK
CIK 1999480
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub